Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia.
Francis S, Lucas C, Lane S, Wang L, Watmough S, Knight K, Bell J, Kaleel-Rahman M, Lee E, O'Brien D, Butt NM, Sadik W, De Soysa L, Seale JR, Salim R, Clark RE. Francis S, et al. Among authors: knight k. Leuk Res. 2013 Jul;37(7):752-8. doi: 10.1016/j.leukres.2013.04.003. Epub 2013 Apr 22. Leuk Res. 2013. PMID: 23618689
The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial.
Austin GM, Knight K, Bell J, Carter A, Heartin E, Watson D, Foroni L, Christmas SE, Polydoros F, Clark RE. Austin GM, et al. Among authors: knight k. Br J Haematol. 2019 May;185(4):791-793. doi: 10.1111/bjh.15629. Epub 2018 Nov 8. Br J Haematol. 2019. PMID: 30408160 Free article. Clinical Trial. No abstract available.
1,170 results